Silence Therapeutics PLC Free Cash Flow Generation Index
Silence Therapeutics PLC free cash flow generation index. Silence Therapeutics PLC (SLN) has a Free Cash Flow Generation Index of 1.00x as of June 2026. Free cash flow of $1.49 Million represents 1% of operating cash flow ($1.49 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Silence Therapeutics PLC (2019–2021)
Free cash flow generation index of Silence Therapeutics PLC from 2019 to 2021. Historical FCF Generation Index trend for Silence Therapeutics PLC across 2 annual periods. See Silence Therapeutics PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Silence Therapeutics PLC Free Cash Flow Generation Index by Year (2019–2021)
Silence Therapeutics PLC free cash flow generation index by year from 2019 to 2021. Year-by-year Free Cash Flow Generation Index for Silence Therapeutics PLC. For the full cash flow conversion analysis, see Silence Therapeutics PLC operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | $7.39 Million | $9.19 Million | $1.80 Million | ▼ -19.2% |
| 2019 | 0.99x | $1.72 Million | $1.73 Million | $9.00K | — |